| Microspheres used in liver radioembolization: from conception to clinical effects P d’Abadie, M Hesse, A Louppe, R Lhommel, S Walrand, F Jamar Molecules 26 (13), 3966, 2021 | 35 | 2021 |
| 90Y TOF-PET based EUD reunifies patient survival prediction in resin and glass microspheres radioembolization of HCC tumours P d’Abadie, M Hesse, F Jamar, R Lhommel, S Walrand Physics in Medicine & Biology 63 (24), 245010, 2018 | 31 | 2018 |
| Mortality in patients with high risk Staphylococcus aureus bacteremia undergoing or not PET-CT: a single center experience H Yildiz, G Reychler, H Rodriguez-Villalobos, L Orioli, P D'Abadie, ... Journal of Infection and Chemotherapy 25 (11), 880-885, 2019 | 17 | 2019 |
| Prediction of tumor response and patient outcome after radioembolization of hepatocellular carcinoma using 90Y-PET-computed tomography dosimetry P d’Abadie, S Walrand, M Hesse, L Annet, I Borbath, M Van den Eynde, ... Nuclear medicine communications 42 (7), 747-754, 2021 | 16 | 2021 |
| Accurate non-tumoral 99mTc-MAA absorbed dose prediction to plan optimized activities in liver radioembolization using resin microspheres P d'Abadie, S Walrand, M Hesse, N Amini, R Lhommel, K Sawadogo, ... Physica Medica 89, 250-257, 2021 | 14 | 2021 |
| Hibernoma mimicking liposarcoma L Pothen, P D'Abadie, A Kozyreff, A Mourin, L Coubeau The Lancet 392 (10143), 244, 2018 | 13 | 2018 |
| Antireflux catheter improves tumor targeting in liver radioembolization with resin microspheres P d’Abadie, S Walrand, P Goffette, N Amini, A van Maanen, R Lhommel, ... Diagnostic and Interventional Radiology 27 (6), 768, 2021 | 12 | 2021 |
| Hemophagocytic lymphohistiocytosis in adults: a retrospective study in a Belgian teaching hospital H Yildiz, D Castanares-Zapatero, P d’Abadie, S Bailly, JC Yombi International journal of general medicine 15, 8111, 2022 | 9 | 2022 |
| Metastatic cutaneous apocrine adenocarcinoma successfully treated with systemic anti‐androgen therapy—A case report F Collette, M Hamoir, P Van Eeckhout, P D’Abadie, T Duprez, S Schmitz, ... Clinical case reports 8 (12), 3471-3477, 2020 | 9 | 2020 |
| Yttrium-90 TOF-PET-based EUD predicts response post liver radioembolizations using recommended manufacturer FDG reconstruction parameters M Hesse, P d’Abadie, R Lhommel, F Jamar, S Walrand Frontiers in oncology 11, 592529, 2021 | 7 | 2021 |
| Hepatic arterial buffer response in liver radioembolization and potential use for improved cancer therapy S Walrand, M Hesse, P d’Abadie, F Jamar Cancers 13 (7), 1537, 2021 | 6 | 2021 |
| An unusual case of cardiac tamponade: bronchogenic cyst infection due to Salmonella bredeney H Yildiz, R Reichwein, A Poncelet, V Lacroix, P D'abadie, B Ghaye, ... Journal of infection and chemotherapy 25 (2), 151-153, 2019 | 6 | 2019 |
| TCP post-radioembolization and TCP post-EBRT in HCC are similar and can be predicted using the in vitro radiosensitivity P d’Abadie, S Walrand, M Hesse, I Borbath, R Lhommel, F Jamar EJNMMI research 12 (1), 40, 2022 | 5 | 2022 |
| The Role of Quantitative and Semi-quantitative [18F]FDG-PET/CT Indices for Evaluating Disease Activity and Management of Patients With Dermatomyositis and … H Yildiz, P D'abadie, O Gheysens Frontiers in medicine 9, 883727, 2022 | 5 | 2022 |
| A case report of cutaneous leishmaniasis: a misleading clinical presentation C Vanlier, L Marot, E Laranaga, P D’abadie, JC Yombi, H Yildiz, M Baeck Infection 49, 177-180, 2021 | 5 | 2021 |
| Sorafenib Reduced Significantly Heptopulmonary Shunt in a Large Hepatocelullar Carcinoma RL P. d'Abadie, I. Borbath, P. Goffette, N. Amini clinical nuclear medicine 44, 70-71, 2018 | 5* | 2018 |
| Optimization of the Clinical Effectiveness of Radioembolization in Hepatocellular Carcinoma with Dosimetry and Patient-Selection Criteria P d’Abadie, S Walrand, R Lhommel, M Hesse, I Borbath, F Jamar Current Oncology 29 (4), 2422-2434, 2022 | 4 | 2022 |
| A theranostic approach in SIRT: value of pre-therapy imaging in treatment planning P d’Abadie, S Walrand, R Lhommel, M Hesse, F Jamar Journal of clinical medicine 11 (23), 7245, 2022 | 3 | 2022 |
| Diagnostic Superiority of Dual-Time Point [18F]FDG PET/CT to Differentiate Malignant from Benign Soft Tissue Tumors P d’Abadie, O Gheysens, R Lhommel, F Jamar, T Kirchgesner, F Mazzeo, ... Diagnostics 13 (20), 3202, 2023 | 1 | 2023 |
| Hyoepiglottic Rheumatoid Nodule Mimicking Head and Neck Malignancy on 18F-FDG PET/CT L Opalinski, S Schmitz, P Van Eeckhout, P d’Abadie, O Gheysens Clinical Nuclear Medicine 48 (2), e80-e81, 2023 | 1 | 2023 |
